Article info
PDFClinical and epidemiological research
Extended report
Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial
- Correspondence to Karen Hambardzumyan, Department of Medicine, Clinical Therapy Research, Inflammatory Diseases (ClinTRID), Karolinska Institute, D1:00 Karolinska University Hospital, Solna, Stockholm 17176, Sweden; karen.hambardzumyan{at}ki.se
Citation
Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial
Publication history
- Received November 27, 2013
- Revised April 4, 2014
- Accepted April 13, 2014
- First published May 8, 2014.
Online issue publication
July 13, 2020
Article Versions
- Previous version (13 July 2020).
- Previous version (13 July 2020).
- Previous version (13 July 2020).
- Previous version (13 July 2020).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Files in this Data Supplement:
- Data supplement 1 - Online figures
- Data supplement 2 - Online table 1
- Data supplement 3 - Online table 2
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/